Abordaje integral del cáncer gástrico avanzado - page 62

SEGUNDA LÍNEA ACTUAL

TRATAMIENTO

SEGUNDA LÍNEA

QMT

PACLITAXEL +

RAMUCIRUMAB

NO QMT

RAMUCIRUMAB

CONTRAINDICACIÓN

RAMUCIRUMAB

DOCETAXEL

IRINOTECAN

PACLITAXEL

SLP > 4 m

RETRATAMIENTO

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,52,53,54,55,56,57,58,59,60,61 63,64,65